MUSC Children's Hospital MUSC Children's Hospital
  We're all about children!

  Home
  About Us
  Divisions
  Ask a Med-U-Nurse
  Health Library
  Find a Doctor
  For Physicians
  Job Opportunities
  Make a Difference
  News & Events
   News Room
   Kids Connection Newsletter
   Support Groups
   Special Events
   Parenting Newsletter
   Parenting Classes
   Community Classes
   Grand Rounds Schedule

  Research
  Residents & Fellows
  Your Hospital Visit



171 Ashley Ave.
Charleston, SC 29425
843-792-1414
800-424-MUSC


printPrint Version


October 2005
Children's Research Institute News Brief

Dr. Maria
Bernard L. Maria, MD, MBA
Executive Director
Darby Children's Research Inst.
Inderjit Singh, PhD
Inderjit Singh, PhD
Scientific Director
Darby Children's Research Inst.


In this issue of Kids Connection, we highlight the Division of Infectious Disease and the great work of Drs. Johnson and Fowler. Dr. Sandi Fowler has just received Institutional Review Board (IRB) approval for a new research project collecting spinal fluid samples from children having lumbar punctures for diagnostic reasons. The plan is to analyze proteins within the spinal fluid to define parameters of inflammation that could then be used as part of efforts to translate use of exciting new compounds discovered in the Darby Children's Research Institute (DCRI) into clinical trials in children with brain inflammatory conditions, such as encephalitis and brain tumors. Dr. Fowler is setting a wonderful example for pediatric physicians reaching out to DCRI collaborators and resources by making use of our Proteomics Center expertise (Drs. Knapp and Baatz) and its technologies.

Proteomics refers to the study of the proteins produced by any given species, tissue samples (normal or diseased), blood, plasma, serum, or cell line. Proteomic analyses of biological samples aim to determine the overall set of proteins involved in normal cellular physiology or altered by a disease process, and involve a series of procedures that allow the identification of any protein that may be relevant to any disease. Moreover, advances in machine learning and pattern recognition have rendered single biomarker identification a special case of a more general (and accurate) identification of meaningful patterns of biomarkers (proteomic profiles). Examples of proteomics are 1) Expression proteomics which is the measurement of protein levels in health and disease and 2) Cell map proteomics which is the measurement of protein composition within specific areas of a cell to understand how each protein is involved in specific diseases. These and other types of proteomic analysis promise to unlock the mystery of many diseases affecting children and to devise new treatments to improve children's health.

Why do researchers study proteomics?
First of all genomics, which looks at gene expression, does not reveal function of the protein derived from a specific gene. Second, with proteomics a researcher can study tissue and cell-dependent protein profile (not fixed as the genome is). Finally, protein expression patterns are dependent on developmental stage and are influenced by environment, both of which are important factors in determining the health of children.

When should proteomic approaches be considered in children's research?
If your research involves the study of proteins, proteomics approaches may be applicable. If you already do 2D gel separations of your proteins and need to identify spots on your gels, the MUSC Mass Spectrometry Facility offers protein identification services. Please contact facility director, Dr. Kevin Schey or facility manager, Jennifer Bethard for more information.

If you would like to apply other mass spectrometry-based proteomic approaches you may have read about or heard about (e.g. MALDI profiling ["SELDI"] or liquid chromatography - mass spectrometry approaches), MUSC is well equipped for these approaches, but the Mass Spectrometry Facility does not yet offer these methods on a service basis. Investigators using these methods are doing so via their graduate students or postdoctoral fellows working in the facility. To discuss how these approaches might be applied to your research, contact Dr. Dan Knapp, director of the MUSC Proteomics Center.

If you need help with 2D gel methods, contact Dr. John Baatz, director of the MUSC Gel Proteomics Facility. This facility offers 2D gel services ranging from consultation to actually running gels for you, including differential expression gels (the "DIGE" method). For links to the Web pages of the various proteomics facilities at MUSC, see www.proteomics.musc.edu.


Terms and Conditions | Privacy Policy | Site Map | Contact Us